APA (7th ed.) Citation

F, T., MP, Y., G, K., A, P., C, M., K, M., . . . A, A. (2025). Clinicopathological data and the role of miRNA expression in patients with pheochromocytomas/paragangliomas. Frontiers in endocrinology, 16, 1716806. https://doi.org/10.3389/fendo.2025.1716806

Chicago Style (17th ed.) Citation

F, Thanasoula, et al. "Clinicopathological Data and the Role of MiRNA Expression in Patients with Pheochromocytomas/paragangliomas." Frontiers in Endocrinology 16 (2025): 1716806. https://doi.org/10.3389/fendo.2025.1716806.

MLA (9th ed.) Citation

F, Thanasoula, et al. "Clinicopathological Data and the Role of MiRNA Expression in Patients with Pheochromocytomas/paragangliomas." Frontiers in Endocrinology, vol. 16, 2025, p. 1716806, https://doi.org/10.3389/fendo.2025.1716806.